Evidence map›Paper›PMID 36448288›Full record

ReviewJournal of the Royal Society, Interface2022

Biology and medicine in the landscape of quantum advantages.

Benjamin A Cordier, Nicolas P D Sawaya, Gian Giacomo Guerreschi, Shannon K McWeeney

Abstract readReview
In one paragraph

Review in Journal of the Royal Society, Interface, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Quantum biology: From mechanisms to medicine.Clinical and translational medicine · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Surrogate optimization of variational quantum circuits.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Developing a quantum computing model for sequence annotation of interferon protein.Computational and structural biotechnology journal · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Benjamin A CordierDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, OR 97202, USA.ORCID 0000-0001-5122-7879
Nicolas P D SawayaIntel Labs, Santa Clara, CA 95054, USA.
Gian Giacomo GuerreschiIntel Labs, Santa Clara, CA 95054, USA.
Shannon K McWeeneyDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, OR 97202, USA.

Funding

TRAINING PROGRAM IN HEALTH INFORMATICST15LM007088 · NLM · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAM R HERSH, Vishnu Mohan · 1992 to 2026
$23.4M
NLM NIH HHS T15 LM007088
6 · The paper itself

Abstract

Quantum computing holds substantial potential for applications in biology and medicine, spanning from the simulation of biomolecules to machine learning methods for subtyping cancers on the basis of clinical features. This potential is encapsulated by the concept of a quantum advantage, which is contingent on a reduction in the consumption of a computational resource, such as time, space or data. Here, we distill the concept of a quantum advantage into a simple framework to aid researchers in biology and medicine pursuing the development of quantum applications. We then apply this framework to a wide variety of computational problems relevant to these domains in an effort to (i) assess the potential of practical advantages in specific application areas and (ii) identify gaps that may be addressed with novel quantum approaches. In doing so, we provide an extensive survey of the intersection of biology and medicine with the current landscape of quantum algorithms and their potential advantages. While we endeavour to identify specific computational problems that may admit practical advantages throughout this work, the rapid pace of change in the fields of quantum computing, classical algorithms and biological research implies that this intersection will remain highly dynamic for the foreseeable future.

Indexed as

Computing MethodologiesQuantum TheoryAlgorithmsBiologyComputer Simulationbioinformaticscomputational biologymedicinequantum advantagequantum computing

Identifiers

PMID36448288
PMCPMC9709576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.